Azurity All-Hands Company Meeting

Sep 11, 2019

WOBURN, Mass. (September 11, 2019) – This September two companies met and became one, Azurity Pharmaceuticals is the beginning of that new family. This was a time to meet and get to know each other and build as an organization. The combination of the two legacy companies makes the future limitless, our platform is unique and truly allows us to make a difference in the lives of our patients each and every day.

Previous Image
Next Image

info heading

info content


Back to News and Events

Home

 

Company

About Us
Company Culture
Management Team
Board of Directors

FDA-Approved Oral Liquids

FIRVANQ® | Epaned® | Qbrelis® | Katerzia® | Xatmep®

FIRST® KITS for Compounding

Portfolio of Kits

Resources

News & Events
Compliance
Careers

Contact Us

Terms of Use | Privacy Policy and Cookie Notice

Azurity Pharmaceuticals, Inc. was formerly known as known as CutisPharma, Inc., parent company of Silvergate Pharmaceuticals, Inc. Product labeling, packaging, and imagery are for representation purposes only and may reflect Azurity, CutisPharma, or Silvergate.

The Information contained herein, including product information, is intended only for residents of the United States.

© 2019-2020 Azurity Pharmaceuticals, Inc. All Rights Reserved. All Trademarks referred to are the property of their respective owners. WEB-AZ-2.0